Subscribe to Email Updates

    Med Tech Success Story | 2 min read

    LaunchPad Alumni, Atacor, Raises $25M

    AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development

    Full Post from Businesswire

    SAN CLEMENTE, Calif.--()--AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, includes existing investors Broadview Ventures and aMoon Fund as well as new investors Hatteras Venture Partners, Catalyst Health Ventures (CHV) and Longview Ventures, a Broadview affiliate. The investment supports efforts to reach US and EU regulatory clearances for AtaCor’s novel extracardiac temporary pacing system as well as development efforts for additional extracardiac therapies.

    “It is a great vote of confidence to close this $25M financing round and continue AtaCor’s dedicated work to develop our novel pacing therapy,” said Rick Sanghera, AtaCor’s CEO. “We appreciate the support of the investor syndicate and look forward to finishing development and building further clinical evidence to bring our technology to patients.”

    AtaCor is developing novel cardiac pacing therapies that do not require any hardware to be placed inside or onto a patient’s heart. The technology has already completed early clinical evaluation and will offer an important alternative treatment option for patients requiring bradycardia pacing support.

    “AtaCor’s technology promises to be a step change in cardiac pacing. With early clinical data in hand, the company is now poised to develop the technology through regulatory approval, and we are thrilled to be supporting that work,” said Maria Berkman, of Broadview Ventures and Longview Ventures.

    Read the full press release here.


    Rick Sanghera, Atacor CEO, says...

    "[I have] Nothing but great things to say about the program [LaunchPad].  Octane really helped to hone our initial pitch deck and focus on the important bullets that catch the eyes of the venture community.  Winning the MTIF 2018 Award was a great step in validating the AtaCor story and we continue to work with partners that we met through the Octane network… in fact Clay Wilemon and the team Brado just helped us launch our new website and animation over this past weekend."

    Related Categories

    Med Tech Success Story

    Let Us Know What You Thought about this Post.

    Put your Comment Below.

    You may also like:

    Events Med Tech

    Politically Incorrect Diversity in Clinical Trials

    Read the full article on

    Med Tech Start Up Octane News

    LaunchPad Announces Top 8 Presenting Companies at MedTech Innovation Forum 2021

    September 29, 2021, Aliso Viejo, CA. Octane, Southern California's leading accelerator announced today the top 8 LaunchP...

    Events Med Tech

    Octane CEO: ‘We must not become complacent’ on innovation

    Original article can be found on